268 related articles for article (PubMed ID: 23673306)
41. Differential allelic expression of SOS1 and hyperexpression of the activating SOS1 c.755C variant in a Noonan syndrome family.
Moncini S; Bonati MT; Morella I; Ferrari L; Brambilla R; Riva P
Eur J Hum Genet; 2015 Nov; 23(11):1531-7. PubMed ID: 25712082
[TBL] [Abstract][Full Text] [Related]
42. Pigmented villonodular synovitis in a patient with Noonan syndrome and SOS1 gene mutation.
Mascheroni E; Digilio MC; Cortis E; Devito R; Sarkozy A; Capolino R; Dallapiccola B; Ugazio AG
Am J Med Genet A; 2008 Nov; 146A(22):2966-7. PubMed ID: 18925667
[No Abstract] [Full Text] [Related]
43. Atrophoderma Vermiculatum: A Cutaneous Feature of Loeys-Dietz Syndrome.
van Dijk FS; Brittain H; Boerma R; Robert ML; Cobben JM
JAMA Dermatol; 2015 Jun; 151(6):675-7. PubMed ID: 25564957
[No Abstract] [Full Text] [Related]
44. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
Tartaglia M; Pennacchio LA; Zhao C; Yadav KK; Fodale V; Sarkozy A; Pandit B; Oishi K; Martinelli S; Schackwitz W; Ustaszewska A; Martin J; Bristow J; Carta C; Lepri F; Neri C; Vasta I; Gibson K; Curry CJ; Siguero JP; Digilio MC; Zampino G; Dallapiccola B; Bar-Sagi D; Gelb BD
Nat Genet; 2007 Jan; 39(1):75-9. PubMed ID: 17143282
[TBL] [Abstract][Full Text] [Related]
45. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
Denayer E; Devriendt K; de Ravel T; Van Buggenhout G; Smeets E; Francois I; Sznajer Y; Craen M; Leventopoulos G; Mutesa L; Vandecasseye W; Massa G; Kayserili H; Sciot R; Fryns JP; Legius E
Genes Chromosomes Cancer; 2010 Mar; 49(3):242-52. PubMed ID: 19953625
[TBL] [Abstract][Full Text] [Related]
46. Ocular findings in Noonan syndrome: a retrospective cohort study of 105 patients.
van Trier DC; van der Burgt I; Draaijer RW; Cruysberg JRM; Noordam C; Draaisma JM
Eur J Pediatr; 2018 Aug; 177(8):1293-1298. PubMed ID: 29948256
[TBL] [Abstract][Full Text] [Related]
47. [Noonan syndrome: differential diagnosis with Turner's syndrome].
de Majo SF; de Otero BC; Reichmann A
Bol Med Hosp Infant Mex; 1979; 36(6):1089-97. PubMed ID: 486254
[TBL] [Abstract][Full Text] [Related]
48. Acute lymphoblastic leukemia in the context of RASopathies.
Cavé H; Caye A; Strullu M; Aladjidi N; Vignal C; Ferster A; Méchinaud F; Domenech C; Pierri F; Contet A; Cacheux V; Irving J; Kratz C; Clavel J; Verloes A
Eur J Med Genet; 2016 Mar; 59(3):173-8. PubMed ID: 26855057
[TBL] [Abstract][Full Text] [Related]
49. Hereditary woolly hair and keratosis pilaris.
Chien AJ; Valentine MC; Sybert VP
J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S35-9. PubMed ID: 16427989
[TBL] [Abstract][Full Text] [Related]
50. SOS1 mutations in Noonan syndrome: Cardiomyopathies and not only congenital heart defects! Report of six patients including two novel variants and literature review.
Baban A; Olivini N; Lepri FR; Calì F; Mucciolo M; Digilio MC; Calcagni G; di Mambro C; Dallapiccola B; Adorisio R; Novelli A; Drago F
Am J Med Genet A; 2019 Oct; 179(10):2083-2090. PubMed ID: 31368652
[TBL] [Abstract][Full Text] [Related]
51. The association of keratosis pilaris atrophicans and woolly hair, with and without Noonan's syndrome.
Neild VS; Pegum JS; Wells RS
Br J Dermatol; 1984 Mar; 110(3):357-62. PubMed ID: 6696850
[TBL] [Abstract][Full Text] [Related]
52. Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation.
Nazarenko SA; Ostroverkhova NV; Vasiljeva EO; Nazarenko LP; Puzyrev VP; Malet P; Nemtseva TA
Am J Med Genet; 1999 Jul; 85(2):179-82. PubMed ID: 10406673
[TBL] [Abstract][Full Text] [Related]
53. Ulerythema ophryogenes in Cornelia de Lange syndrome.
Flórez A; Fernández-Redondo V; Toribio J
Pediatr Dermatol; 2002; 19(1):42-5. PubMed ID: 11860570
[TBL] [Abstract][Full Text] [Related]
54. Noonan syndrome and its related disorders.
Fukushima Y
Acta Paediatr Jpn; 1996 Feb; 38(1):102-4. PubMed ID: 8992851
[TBL] [Abstract][Full Text] [Related]
55. Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.
Gripp KW; Zand DJ; Demmer L; Anderson CE; Dobyns WB; Zackai EH; Denenberg E; Jenny K; Stabley DL; Sol-Church K
Am J Med Genet A; 2013 Oct; 161A(10):2420-30. PubMed ID: 23918763
[TBL] [Abstract][Full Text] [Related]
56. Multiple spinal nerve enlargement and SOS1 mutation: Further evidence of overlap between neurofibromatosis type 1 and Noonan phenotype.
Santoro C; Giugliano T; Melone MAB; Cirillo M; Schettino C; Bernardo P; Cirillo G; Perrotta S; Piluso G
Clin Genet; 2018 Jan; 93(1):138-143. PubMed ID: 28456002
[TBL] [Abstract][Full Text] [Related]
57. Treatment for ulerythema ophryogenes with hydrocortisone ointment.
EDELSTEIN AJ
AMA Arch Derm; 1955 Apr; 71(4):450. PubMed ID: 14360752
[No Abstract] [Full Text] [Related]
58. Prolapse of all cardiac valves in Noonan syndrome.
Otikunta AN; Subbareddy YV; Polamuri P; Thakkar A
BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25716036
[TBL] [Abstract][Full Text] [Related]
59. A further patient with Noonan syndrome due to a SOS1 mutation and rhabdomyosarcoma.
Hastings R; Newbury-Ecob R; Ng A; Taylor R
Genes Chromosomes Cancer; 2010 Oct; 49(10):967-8. PubMed ID: 20607846
[No Abstract] [Full Text] [Related]
60. CFC syndrome: a syndrome distinct from Noonan syndrome.
Verloes A; Le Merrer M; Soyeur D; Kaplan J; Pangalos C; Rigo J; Briard ML
Ann Genet; 1988; 31(4):230-4. PubMed ID: 3265306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
